Oncotherm

This article has multiple issues. Please help or discuss these issues on the talk page. (Learn how and when to remove these template messages) This article contains content that is written like an advertisement. Please help by removing promotional content and inappropriate external links, and by adding encyclopedic content written from a neutral point of view. (February 2022) (Learn how and when to remove this template message) This article needs additional citations for verification. Please help by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources:  –  ·  ·  · scholar · JSTOR (February 2022) (Learn how and when to remove this template message) This article may contain excessive or inappropriate references to self-published sources. Please help by removing references to unreliable sources where they are used inappropriately. (February 2022) (Learn how and when to remove this template message) (Learn how and when to remove this template message)

Oncotherm medical devices are produced by Oncotherm Ltd. and used for cancer treatment.

Methodology[]

The company's methodology is based on the view of its founder that the heat-dose sensitive characterization of tissue is at the core of the oncothermia treatment.^[1] The tumor tissue has lower impedance than the surrounding tissues,^{[citation needed]} so most of the energy is transmitted and absorbed by the cancerous lesion. This selection of the tumor tissues (self-focusing) renders external focusing unnecessary.^[2]

Company[]

Oncotherm Ltd. was founded in 1988 by Prof. Dr. András Szász^[3] in Hungary. In 2002 it received investment from a German company and was reorganized as a German-Hungarian company consisting of Oncotherm Hungary Ltd^[4] and Oncotherm GmbH.^[5]

Medical devices[]

Their main products are the Oncotherm EHY-2000^[6] and the Oncotherm EHY-2030,^[7] hyperthermia devices using the thermo-electric effects of electrical fields.

More than 450 devices have been placed into operation, mostly in Germany and South Korea, and performed over 400,000 treatments.^[8] The devices are not approved by the U.S. Food and Drug Administration.

References[]